Skip to main content
. 2012 Jul-Sep;16(3):196–199.

Table 1. Frequency of mucositis/stomatitis, xerostomia and dysgeusia after cancer treatment with certain molecularly targeted drugs.

graphic file with name hippokratia-16-197-i001.jpg

†multiple tyrosine kinase inhibitor, ‡in combination with radiotherapy, §in combination with 5-FU and leucovorin, ¶in patients with previous bevacizumab treatmentSIDS: Frequent oral side-effects of targeted cancer therapy